ENVOY MEDICAL INC (COCH) Stock Overview
USA - NASDAQ:COCH - US29415V1098 - Common Stock
COCH Key Statistics, Chart & Performance
The current stock price of COCH is 1.6 USD. In the past month the price decreased by -38.88%. In the past year, price decreased by -69.78%.
COCH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.15 | 231.52B | ||
| ISRG | INTUITIVE SURGICAL INC | 54.78 | 158.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.89 | 142.10B | ||
| SYK | STRYKER CORP | 28.73 | 141.16B | ||
| MDT | MEDTRONIC PLC | 17.78 | 126.13B | ||
| BDX | BECTON DICKINSON AND CO | 13.49 | 55.18B | ||
| IDXX | IDEXX LABORATORIES INC | 52.23 | 50.18B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.85 | 45.04B | ||
| RMD | RESMED INC | 29.66 | 41.48B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.98 | 34.01B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.57 | 26.80B | ||
| DXCM | DEXCOM INC | 38.84 | 25.89B |
Related stock screener links
About COCH
Company Profile
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Company Info
ENVOY MEDICAL INC
4875 White Bear Parkway
White Bear Lake MINNESOTA US
Employees: 42
Phone: 16513618000
ENVOY MEDICAL INC / COCH FAQ
What is the stock price of ENVOY MEDICAL INC today?
The current stock price of COCH is 1.6 USD. The price increased by 97.53% in the last trading session.
What is the ticker symbol for ENVOY MEDICAL INC stock?
The exchange symbol of ENVOY MEDICAL INC is COCH and it is listed on the Nasdaq exchange.
On which exchange is COCH stock listed?
COCH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENVOY MEDICAL INC stock?
9 analysts have analysed COCH and the average price target is 7.65 USD. This implies a price increase of 378.13% is expected in the next year compared to the current price of 1.6. Check the ENVOY MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENVOY MEDICAL INC worth?
ENVOY MEDICAL INC (COCH) has a market capitalization of 35.04M USD. This makes COCH a Nano Cap stock.
How many employees does ENVOY MEDICAL INC have?
ENVOY MEDICAL INC (COCH) currently has 42 employees.
What are the support and resistance levels for ENVOY MEDICAL INC (COCH) stock?
ENVOY MEDICAL INC (COCH) has a resistance level at 0.82. Check the full technical report for a detailed analysis of COCH support and resistance levels.
Is ENVOY MEDICAL INC (COCH) expected to grow?
The Revenue of ENVOY MEDICAL INC (COCH) is expected to decline by -17.84% in the next year. Check the estimates tab for more information on the COCH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ENVOY MEDICAL INC (COCH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of COCH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of COCH, evaluating the profitability, health, valuation and growth aspects
- ENVOY MEDICAL INC (COCH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENVOY MEDICAL INC (COCH) Sales and EPS estimates to see what analysts future expectations are.
- ENVOY MEDICAL INC (COCH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENVOY MEDICAL INC (COCH) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENVOY MEDICAL INC (COCH) Stock Chart to make your own analysis
- ENVOY MEDICAL INC (COCH) Latest news and press-releases to stay up to date.
Does ENVOY MEDICAL INC (COCH) stock pay dividends?
COCH does not pay a dividend.
When does ENVOY MEDICAL INC (COCH) report earnings?
ENVOY MEDICAL INC (COCH) will report earnings on 2025-11-14, after the market close.
What is the Price/Earnings (PE) ratio of ENVOY MEDICAL INC (COCH)?
ENVOY MEDICAL INC (COCH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.44).
What is the Short Interest ratio of ENVOY MEDICAL INC (COCH) stock?
The outstanding short interest for ENVOY MEDICAL INC (COCH) is 1.73% of its float. Check the ownership tab for more information on the COCH short interest.
COCH Technical Analysis
COCH Financial Highlights
Over the last trailing twelve months COCH reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS decreased by -90.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -284.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
COCH Forecast & Estimates
9 analysts have analysed COCH and the average price target is 7.65 USD. This implies a price increase of 378.13% is expected in the next year compared to the current price of 1.6.
For the next year, analysts expect an EPS growth of 9.67% and a revenue growth -17.84% for COCH